Dyno Therapeutics
Kathy is a computational biologist with expertise in machine learning and RNA biology. She completed her PhD in the Computational and Systems Biology program at MIT under David Bartel, where she developed biochemically informed models of miRNA targeting. Uing high-throughput measurements of miRNA-target binding affinities in vitro, she modeled miRNA-mediated repression in vivo and built a machine learning framework for predicting miRNA-target binding affinities from sequence. Her work has been published in leading journals, including Science and Molecular Cell. She enjoys board games, video games, and cooking.
This person is not in the org chart
This person is not in any offices
Dyno Therapeutics
4 followers
Dyno Therapeutics is a Cambridge based, VC-backed biotech startup that uses next-gen DNA technologies and machine learning to engineer Adeno-associated Virus (AAV) capsids for effective delivery of gene therapies.